<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>SBIR Phase II:  Information Theoretic Learning and Application to Fetal ECG</AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>02/15/2003</AwardEffectiveDate>
<AwardExpirationDate>01/31/2006</AwardExpirationDate>
<AwardTotalIntnAmount>499578.00</AwardTotalIntnAmount>
<AwardAmount>595578</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>07070000</Code>
<Directorate>
<Abbreviation>ENG</Abbreviation>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<Abbreviation>IIP</Abbreviation>
<LongName>Div Of Industrial Innovation &amp; Partnersh</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Errol Arkilic</SignBlockName>
<PO_EMAI/>
<PO_PHON/>
</ProgramOfficer>
<AbstractNarration>This Small Business Innovation Phase II Project will  develop information theoretic methods to separate fetal electrocardiogram (FECG) signals from the noisy electrical environment of the maternal abdomen based on statistical properties of the mixtures (blind source separation).  The separation is done using a recently introduced algorithm (Mermaid) that is computationally and data efficient.  Phase I research showed that Mermaid is a marked improvement over prior methods of FECG separation.  The project will develop the technology for a comprehensive fetal and maternal monitor including fetal heart rate, FECG, and maternal Electrohysterogram (EHG, which measures contraction information) in a very compact device.  The project includes clinical studies designed to provide the information necessary to create and validate NeuroDimension's system and also to illustrate its effectiveness. &lt;br/&gt; &lt;br/&gt;Potential markets include hospital-based fetal monitoring, home/physician's office fetal monitoring and stress tests, and use as a research tool.  The monitor not only will be less expensive than current monitors, but also will provide additional information that can dramatically improve patient care and reduce costs by avoiding unnecessary procedures.&lt;br/&gt;</AbstractNarration>
<MinAmdLetterDate>02/14/2003</MinAmdLetterDate>
<MaxAmdLetterDate>06/21/2005</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.041</CFDA_NUM>
<NSF_PAR_USE_FLAG>0</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>0239060</AwardID>
<Investigator>
<FirstName>Neil</FirstName>
<LastName>Euliano</LastName>
<PI_MID_INIT>R</PI_MID_INIT>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Neil R Euliano</PI_FULL_NAME>
<EmailAddress>neil@conveng.com</EmailAddress>
<PI_PHON>3523784899</PI_PHON>
<NSF_ID>000484411</NSF_ID>
<StartDate>02/14/2003</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>Convergent Engineering, Inc</Name>
<CityName>Gainesville</CityName>
<CountyName>ALACHUA</CountyName>
<ZipCode>326075775</ZipCode>
<PhoneNumber>3523784899</PhoneNumber>
<StreetAddress>100 SW 75th Street</StreetAddress>
<StreetAddress2>Suite 106</StreetAddress2>
<CountryName>United States</CountryName>
<StateName>Florida</StateName>
<StateCode>FL</StateCode>
<CONGRESSDISTRICT>03</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_ORG>FL03</CONGRESS_DISTRICT_ORG>
<ORG_DUNS_NUM>176698624</ORG_DUNS_NUM>
<ORG_LGL_BUS_NAME>CONVERGENT ENGINEERING, INC.</ORG_LGL_BUS_NAME>
<ORG_PRNT_DUNS_NUM/>
</Institution>
<Performance_Institution>
<Name><![CDATA[Convergent Engineering, Inc]]></Name>
<CityName>Gainesville</CityName>
<CountyName>ALACHUA</CountyName>
<StateCode>FL</StateCode>
<ZipCode>326075775</ZipCode>
<StreetAddress><![CDATA[100 SW 75th Street]]></StreetAddress>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>Florida</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>03</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF>FL03</CONGRESS_DISTRICT_PERF>
</Performance_Institution>
<FoaInformation>
<Code>0116000</Code>
<Name>Human Subjects</Name>
</FoaInformation>
<FoaInformation>
<Code>0510604</Code>
<Name>Analytic Tools</Name>
</FoaInformation>
<ProgramElement>
<Code>5373</Code>
<Text>SBIR Phase II</Text>
</ProgramElement>
<ProgramReference>
<Code>9102</Code>
<Text>WOMEN, MINORITY, DISABLED, NEC</Text>
</ProgramReference>
<ProgramReference>
<Code>9178</Code>
<Text>UNDERGRADUATE EDUCATION</Text>
</ProgramReference>
<ProgramReference>
<Code>9216</Code>
<Text>ADVANCED SOFTWARE TECH &amp; ALGOR</Text>
</ProgramReference>
<ProgramReference>
<Code>9231</Code>
<Text>SUPPL FOR UNDERGRAD RES ASSIST</Text>
</ProgramReference>
<ProgramReference>
<Code>HPCC</Code>
<Text>HIGH PERFORMANCE COMPUTING &amp; COMM</Text>
</ProgramReference>
<Appropriation>
<Code>0103</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>490100</APP_SYMB_ID>
</Appropriation>
<Appropriation>
<Code>0105</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>490100</APP_SYMB_ID>
</Appropriation>
<FUND_OBLG>2003~499578</FUND_OBLG>
<FUND_OBLG>2005~96000</FUND_OBLG>
</Award>
</rootTag>
